← Browse by Condition
Medical Condition

infections

Total Trials
9
Recruiting Now
9
Trial Phases
Phase 2, Phase 1, Phase 3

ClinicalMetric tracks all active clinical trials for infections sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — infections Clinical Trials

How many clinical trials are currently recruiting for infections?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for infections, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for infections?
infections research spans Phase 1 (2 trials), Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a infections clinical trial?
Eligibility criteria for infections trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
1
Top Sponsors
Ottawa Hospital Research Institute 1 trial
Qilu Pharmaceutical Co., Ltd. 1 trial
University Hospital Muenster 1 trial
Octapharma 1 trial
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1 trial

Recruiting Clinical Trials

NCT05969275 Phase 2
Recruiting
Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock
Enrollment
296 pts
Location
Canada
Sponsor
Ottawa Hospital Research Insti...
View Trial →
NCT07124468 Phase 1
Recruiting
Assess the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Meropenem-Pralubactam (Meropenem/FL058) in China Healthy Adult Participants
Enrollment
16 pts
Location
China
Sponsor
Qilu Pharmaceutical Co., Ltd.
View Trial →
NCT05450185
Recruiting
Filter Lifespan in Continuous Renal Replacement Therapy
Enrollment
600 pts
Location
Austria, Brazil, Ger...
Sponsor
University Hospital Muenster
View Trial →
NCT07220915 Phase 3
Recruiting
Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
Enrollment
360 pts
Location
United States, Bulga...
Sponsor
Octapharma
View Trial →
NCT06245746 Phase 1
Recruiting
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Enrollment
9 pts
Location
China
Sponsor
Union Hospital, Tongji Medical...
View Trial →
NCT06911658
Recruiting
Infectious Complications After Esophagectomy
Enrollment
350 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT07050693
Recruiting
Efficacy of a 2'-Fucosylactose-based Food Supplement on the Prevention of Respiratory and Gastrointestinal Infections.
Enrollment
100 pts
Location
Italy
Sponsor
University of Bari
View Trial →
NCT05881447
Recruiting
Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Enrollment
1,200 pts
Location
Tanzania
Sponsor
Swiss Tropical & Public Health...
View Trial →
NCT06384651 Phase 4
Recruiting
Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty
Enrollment
40 pts
Location
United States
Sponsor
The Methodist Hospital Researc...
View Trial →

Related Conditions

anemia (2) septic shock (1) sepsis (1) pathologic processes (1) shock (1) systemic inflammatory response syndrome (1) inflammation (1) critically ill (1) continuous renal replacement therapy (1) hypogammaglobulinemia (1) autoimmune conditions (1) rheumatic conditions (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology